血清转基因是一种新的预后生物标志物,用于COVID-19患者

Lei Gao1,2, Ying Liu1,2, Qi-Yuan He1,2

  • 1Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Frontiers in immunology
|December 16, 2024
PubMed
概括

血清转基林水平与2019年新冠病毒病 (COVID-19) 严重程度和不良结果相关. 过林的升高表明COVID-19患者的危急疾病和死亡风险更高.